<DOC>
	<DOCNO>NCT00035828</DOCNO>
	<brief_summary>To determine ABX-IL8 improve shortness breath .</brief_summary>
	<brief_title>A Blinded Study Comparing Safety Efficacy Fully Human Anti-IL8 Monoclonal Antibody ( ABX-IL8 ) Placebo Patients With Chronic Bronchitis COPD</brief_title>
	<detailed_description>Chronic Obstructive Pulmonary Disease ( COPD ) define disease state characterize presence airflow obstruction due chronic bronchitis emphysema . The airflow obstruction generally progressive , may accompany airway hyper-reactivity , may partially reversible . Inflammation lung trigger exposure inhale toxic substance lead tissue damage , mucous secretion , airways narrow tissue destruction . Interleukin-8 ( IL-8 ) play major role elevate sputum patient COPD may contribute tissue destruction . Therefore , highly specific antibody IL-8 ( ABX-IL8 ) may help reduce mucous production tissue destruction .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<criteria>&gt; 50 year old &gt; 20 packyear smoking Diagnosed COPD chronic bronchitis Patients bronchiectasis , cystic fibrosis , tuberculosis , asthma , alpha1 antitrypsin deficiency , CHF Require oxygen therapy Uncontrolled hypertension HIV Hepatitis Recent history COPD exacerbation Patients cancer Recent history infection</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2003</verification_date>
	<keyword>COPD</keyword>
	<keyword>Chronic bronchitis</keyword>
	<keyword>Chronic obstructive pulmonary disease</keyword>
	<keyword>Shortness breath</keyword>
	<keyword>Dyspnea</keyword>
	<keyword>Bronchitis</keyword>
</DOC>